RGC (Regencell Bioscience Holdings) Beginning Cash Position: $0.00 Mil (As of Dec. 2025)


RGC Regencell Bioscience Holdings Ltd RGC
33 GF Score
Price $5.88
! 2 Warning Signs
View Full Analysis

What is Regencell Bioscience Holdings Beginning Cash Position?

Regencell Bioscience Holdings RGC -3.13% 33 Beginning Cash Position is $0.00 Mil as of Dec. 2025. GuruFocus rates RGC with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

Regencell Bioscience Holdings's Beginning Cash Position for the quarter that ended in Dec. 2025 was $0.00 Mil.

Regencell Bioscience Holdings's annual Beginning Cash Position declined from Jun. 2023 ($6.42 Mil) to Jun. 2024 ($1.57 Mil) but then increased from Jun. 2024 ($1.57 Mil) to Jun. 2025 ($2.96 Mil).

Regencell Bioscience Holdings Beginning Cash Position Related Terms

Regencell Bioscience Holdings Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Regencell Bioscience Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regencell Bioscience Holdings Beginning Cash Position Chart

Regencell Bioscience Holdings Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial 0.39 0.06 6.42 1.57 2.96

Regencell Bioscience Holdings Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
RGC
33GF Score
Regencell Bioscience Holdings Ltd RGC
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Regencell Bioscience Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $0.00 Mil mean?
Regencell Bioscience Holdings (RGC) has a Beginning Cash Position of $0.00 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Regencell Bioscience Holdings and its competitors.
Is Regencell Bioscience Holdings' Beginning Cash Position too high?
Regencell Bioscience Holdings' current Beginning Cash Position is $0.00 Mil. Overall, Regencell Bioscience Holdings has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Regencell Bioscience Holdings' Beginning Cash Position compare to SUPN and BCRX?
Regencell Bioscience Holdings' Beginning Cash Position of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Regencell Bioscience Holdings and its competitors. Regencell Bioscience Holdings's current Beginning Cash Position is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regencell Bioscience Holdings stock overvalued right now?
Regencell Bioscience Holdings (RGC) has a current Beginning Cash Position of $0.00 Mil. The current Beginning Cash Position is $0.00 Mil. Regencell Bioscience Holdings' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Regencell Bioscience Holdings (RGC), the current Beginning Cash Position is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regencell Bioscience Holdings Business Description

Address 29 Leighton Road, 9th Floor, Chinachem Leighton Plaza, Causeway Bay, Hong Kong, HKG
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.
33GF Score

Get the complete analysis for RGC

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.88
Price